GRANISETRON FRESENIUS can have side effects. Not all side effects reported for GRANISETRON FRESENIUS are included in this leaflet. Should your general health worsen or if you experience any untoward effects while receiving GRANISETRON FRESENIUS, please consult your healthcare provider for advice.
The most frequent side effects are headache and constipation, which may be temporary.
If any of the following happens, stop receiving GRANISETRON FRESENIUS and tell your doctor immediately:
- Shortness of breath, sudden wheeziness, swelling of the face, eyelids or lips, rash or itching affecting your whole body.
- Dizziness or fainting.
These are all very serious side effects. If you have them, you may have had a serious reaction to GRANISETRON FRESENIUS. You may need urgent medical attention or hospitalisation.
Tell your doctor if you notice any of the following:
Frequent side effects:
- Headache.
- High blood pressure.
- Feeling anxious.
- Restlessness.
- Sleeplessness.
- Drowsiness.
- Dizziness.
- Weakness.
- Loose stools (diarrhoea).
- Constipation.
- Loss of appetite.
- Taste disorder.
- Fever.
- Increase in liver enzymes.
Less frequent side effects:
- Abnormal vision.
- Swelling, including swelling of the face.
- Muscle spasm.
- Uncontrolled movement such as twitching, fidgeting, writhing, wriggling, head bobbing or body swaying.
A condition called serotonin syndrome with symptoms such as high blood pressure, fast heart rate, fever, restlessness, trembling or shaking, sweating, dilated pupils, loose stools, fits and muscle damage.
Heart problems including abnormal heart rhythm and lack of blood flow to the heart.
Low blood pressure.
Liver problems.
Skin rash.
Skin irritation where the injection was given.
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Reporting of side effects
If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the Med Safety APP (Medsafety X SAHPRA) and eReporting platform (who-umc.org) found on SAHPRA website. By reporting side effects, you can help provide more information on the safety of GRANISETRON FRESENIUS. Patients are asked to report any suspected adverse drug reactions to their healthcare provider or Holder of the Certificate of Registration at the following email address: [email protected] and to the relevant medicine’s regulatory authority in the country where the product is marketed.